Diatherix Revenue and Competitors
Estimated Revenue & Valuation
- Diatherix's estimated annual revenue is currently $23.3M per year.
- Diatherix's estimated revenue per employee is $155,000
Employee Data
- Diatherix has 150 Employees.
- Diatherix grew their employee count by -11% last year.
Diatherix's People
Name | Title | Email/Phone |
---|---|---|
1 | Project Manager | Reveal Email/Phone |
Diatherix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.2M | 72 | 9% | N/A | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $2.6M | 17 | 6% | N/A | N/A |
#4 | $1.6M | 10 | -17% | N/A | N/A |
#5 | $17.5M | 113 | -3% | N/A | N/A |
#6 | $0.3M | 2 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 7% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $3.4M | 22 | -15% | N/A | N/A |
#10 | $23.3M | 150 | -11% | N/A | N/A |
What Is Diatherix?
A unique laboratory providing accurate and actionable results in one day for infectious diseases and antibiotic resistance genes utilizing innovative molecular technologies, including proprietary TEM-PCRᅢᄁ¬ダᅡᄁ. Diatherix Eurofins distinctions: - Delivers one-day results - Identifies bacteria regardless of recent antibiotic use - Offers simplicity of single-sample collection - Identifies difficult-to-culture pathogens - Yields a high level of sensitivity and specificity
keywords:N/AN/A
Total Funding
150
Number of Employees
$23.3M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Diatherix News
Diatherix Laboratories, Gen-Probe, Qiagen, F. Hoffmann-La Roche, Cepheid, Life Technologies Corporation, Meridian Biosciences,...
... F.Hoffmann-La Roche, Hain Lifescience, Biomerieux, 3M, Bio-Rad Laboratories, Abacus Diagnostica, Abbott, Puritan Medical, Diatherix.
Previously he served as the Chief Scientific Officer and Clinical Laboratory Director for Diatherix-Eurofins, in Huntsville, Alabama.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $23.3M | 151 | 1% | N/A |
#2 | $48.2M | 151 | 14% | N/A |
#3 | $15M | 153 | -2% | N/A |
#4 | $49.4M | 155 | 3% | N/A |
#5 | $30.9M | 156 | 31% | N/A |